SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-012263
Filing Date
2022-08-04
Accepted
2022-08-04 16:46:40
Documents
67
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q iova-20220630x10q.htm   iXBRL 10-Q 2244422
2 EX-10.1 iova-20220630xex10d1.htm EX-10.1 146738
3 EX-10.2 iova-20220630xex10d2.htm EX-10.2 67161
4 EX-31.1 iova-20220630xex31d1.htm EX-31.1 12337
5 EX-31.2 iova-20220630xex31d2.htm EX-31.2 12224
6 EX-32.1 iova-20220630xex32d1.htm EX-32.1 7091
7 EX-32.2 iova-20220630xex32d2.htm EX-32.2 7163
8 GRAPHIC iova-20220630x10q001.jpg GRAPHIC 152120
  Complete submission text file 0001558370-22-012263.txt   8698073

Data Files

Seq Description Document Type Size
9 EX-101.SCH iova-20220630.xsd EX-101.SCH 43813
10 EX-101.CAL iova-20220630_cal.xml EX-101.CAL 51083
11 EX-101.DEF iova-20220630_def.xml EX-101.DEF 220173
12 EX-101.LAB iova-20220630_lab.xml EX-101.LAB 361351
13 EX-101.PRE iova-20220630_pre.xml EX-101.PRE 328400
61 EXTRACTED XBRL INSTANCE DOCUMENT iova-20220630x10q_htm.xml XML 1508216
Mailing Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD 4TH FLOOR SAN CARLOS CA 94070 6502607120
IOVANCE BIOTHERAPEUTICS, INC. (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36860 | Film No.: 221137396
SIC: 2836 Biological Products, (No Diagnostic Substances)